Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Trava Health

Belle Health
Graded #48

Higher grade

vs+8.400000000000006
Trava Health
Graded #144

Lower grade

The verdict

Belle Health takes it — 77/100 to 68.6/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +12
92
80
Dose & formulationBelle Health +8
72
64
Clinical oversightBelle Health +2
71
69
Labs & monitoringBelle Health +20
72
52
FulfillmentBelle Health +3
85
82
Contract termsEven
55
55
Belle Health · left barTrava Health · right bar

The numbers

MetricBelle HealthTrava Health
WeighScore77/10068.6/100
GradeC+C
Scorecard rank#48#144
Semaglutide$119/mo$119/mo (starting dose, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$198/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Trava Health

Graded #144 · C

Strengths

  • Six named compounding pharmacy partners disclosed in 3rd-party reviews
  • Independent batch testing by Eagle Analytical (FDA-registered lab)
  • Free overnight shipping included
  • No membership fee — pay only for medication
  • HSA/FSA eligible

Where it loses points

  • No LegitScript accreditation badge surfaced
  • BBB F rating with 2 unanswered complaints (BBB file opened 2025-07-07)
  • Clinician roster page returns 404 — no public team listing
  • Founder/CEO not publicly named on site
  • Higher dose pricing gated behind questionnaire (not transparent on public page)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard